NanoEcho Awarded “Nordic IPO of the Year 2024”

NanoEcho has been awarded the “Nordic IPO of the Year 2024” prize at a gala organised by Nordic Listed Leaders (NLL) in Helsinki, Finland.

NLL is a newly established network aimed at connecting and empowering leaders from publicly listed companies across the Nordic region. The award recognises companies whose market listings contribute innovative solutions and positive societal impact, particularly in sustainability, social responsibility, and long-term value creation. NanoEcho has also been featured in one of Finland’s leading business publications, Talouselämä.

“We are delighted that our listing and efforts have been acknowledged. The listing on Nasdaq First North Growth Market has been a significant milestone in the company’s development, and we look forward to continuing our mission to improve diagnostics for rectal cancer and create long-term value for our shareholders,” said Linda Persson, CEO of NanoEcho.

Read more: https://lnkd.in/dkc7rTpx

Nano Echo notering Nasdaq, 6/8-2024